Positive Result for Potential Atopic Dermatitis Treatment
Alphyn Biologics, a clinical-stage dermatology company developing multi-target therapeutics, announced positive results from the first cohort of its Phase 2a clinical trial of AB-101a, a topical therapeutic for mild-to-moderate...
Read More